Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2024)
Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Score Price Valuation Financials Forecast Earnings & Revenue

Ticker	Company	Market Cap	Revenue	EBITDA	Earnings	EPS	Revenue Growth Y/Y	Revenue Growth 5Y	Earnings Growth Y/Y	Earnings Growth 5Y	Earnings Date
AGIO	AGIOS PHARMACEUTICALS INC	$1.96B	$29.40M	-$335.52M	-$352.62M	-$6.32	54.61%	-23.99%	N/A	N/A	2024-06-20
AXSM	AXSOME THERAPEUTICS INC	$3.54B	$270.60M	-$223.54M	-$239.24M	-$5.27	440.80%	N/A	N/A	N/A	2024-05-06
HQY	HEALTHEQUITY INC	$6.77B	$999.59M	$283.57M	$55.71M	$0.65	16.00%	28.33%	N/A	-11.54%	2024-06-21
SLGL	SOL-GEL TECHNOLOGIES LTD	$23.68M	$1.55M	-$26.90M	-$27.24M	-$1.01	-59.98%	64.50%	N/A	N/A	2024-05-10
MRUS	MERUS NV	$2.80B	$43.95M	-$163.72M	-$154.94M	-$3.00	5.68%	2.75%	N/A	N/A	2024-05-07
ZOM	ZOMEDICA CORP	$142.09M	$25.19M	-$33.96M	-$33.64M	-$0.04	33.05%	N/A	N/A	N/A	2024-05-09
COO	COOPER COMPANIES INC	$18.02B	$3.67B	$934.70M	$290.80M	$1.47	8.48%	7.36%	-23.10%	-4.63%	2024-05-30
XBIO	XENETIC BIOSCIENCES INC	$6.58M	$2.54M	-$4.13M	-$4.13M	-$2.71	48.80%	N/A	N/A	N/A	2024-05-09
TLRY	TILRAY BRANDS INC	$1.63B	$743.25M	-$186.62M	-$351.95M	-$0.44	24.65%	30.54%	N/A	N/A
MHUA	MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES CO LTD	$16.35M	$97.10M	$15.80M	$11.63M	$0.49	-6.05%	N/A	81.48%	N/A
FUSN	FUSION PHARMACEUTICALS INC	$1.82B	$2.07M	-$85.08M	-$94.90M	-$1.45	41.55%	N/A	N/A	N/A	2024-06-14
FATE	FATE THERAPEUTICS INC	$402.90M	$63.53M	-$142.65M	-$160.93M	-$1.64	-34.03%	68.05%	N/A	N/A	2024-06-07
ACIU	AC IMMUNE SA	$237.08M	$16.82M	-$58.90M	-$61.63M	-$0.73	316.44%	20.10%	N/A	N/A	2024-06-21
ARGX	ARGENX SE	$22.98B	$38.62M	-$209.00M	-$320.71M	-$5.61	270.16%	9.84%	N/A	N/A	2024-05-09
TRAW	TRAWS PHARMA INC	$13.38M	$226.00k	-$18.93M	-$18.95M	-$0.90	0.00%	-28.72%	N/A	N/A	2024-05-13
VERV	VERVE THERAPEUTICS INC	$536.00M	$11.76M	-$187.55M	-$200.07M	-$3.12	505.77%	N/A	N/A	N/A	2024-05-07
MRKR	MARKER THERAPEUTICS INC	$37.57M	$3.31M	-$8.23M	-$8.24M	-$0.94	-5.76%	74.27%	N/A	N/A	2024-06-06
CVRX	CVRX INC	$192.95M	$39.30M	-$38.73M	-$41.20M	-$1.99	74.89%	N/A	N/A	N/A	2024-06-04
MRK	MERCK & CO INC	$322.94B	$60.12B	$6.90B	$365.00M	$0.14	1.40%	7.29%	-97.56%	-43.06%	2024-06-03
ZVRA	ZEVRA THERAPEUTICS INC	$208.88M	$27.46M	-$43.54M	-$46.05M	-$1.30	170.26%	N/A	N/A	N/A	2024-05-13
RXST	RXSIGHT INC	$2.28B	$89.08M	-$41.04M	-$48.61M	-$1.41	81.77%	N/A	N/A	N/A	2024-06-06
DCPH	DECIPHERA PHARMACEUTICALS INC	$2.05B	$163.36M	-$187.94M	-$194.94M	-$2.29	21.87%	N/A	N/A	N/A	2024-06-20
PROC	PROCAPS GROUP SA	$318.16M	$414.10M	$75.58M	$52.20M	$0.52	-4.80%	N/A	-13.33%	N/A	2024-06-28
CLNN	CLENE INC	$55.87M	$654.00k	-$42.81M	-$49.50M	-$0.47	38.27%	N/A	N/A	N/A	2024-05-29
JANX	JANUX THERAPEUTICS INC	$3.35B	$8.08M	-$56.34M	-$58.29M	-$1.32	-6.14%	N/A	N/A	N/A	2024-06-26
AMS	AMERICAN SHARED HOSPITAL SERVICES	$18.80M	$21.33M	$7.28M	$610.00k	$0.10	8.00%	1.58%	-52.38%	-11.09%	2024-06-25
MTD	METTLER TOLEDO INTERNATIONAL INC	$26.89B	$3.79B	$1.17B	$788.78M	$36.10	-3.35%	5.23%	-6.93%	12.17%	2024-05-09
AEMD	AETHLON MEDICAL INC	$3.64M	$574.25k	-$11.89M	-$12.25M	-$5.09	4,278.20%	20.67%	N/A	N/A	2024-06-26
MASI	MASIMO CORP	$7.25B	$2.05B	$186.40M	$81.50M	$1.54	0.60%	16.91%	-42.54%	-15.94%	2024-06-25
AMGN	AMGEN INC	$166.99B	$29.53B	$12.07B	$3.76B	$7.04	12.76%	4.45%	-52.46%	-11.00%	2024-05-31
NYXH	NYXOAH SA	$279.86M	$4.73M	-$41.92M	-$46.97M	-$1.68	47.25%	N/A	N/A	N/A	2024-06-12
LH	LABORATORY CORP OF AMERICA HOLDINGS	$16.97B	$12.30B	$1.55B	$433.10M	$5.10	4.62%	1.75%	-54.34%	-10.52%	2024-05-14
FLGT	FULGENT GENETICS INC	$643.37M	$287.53M	-$127.63M	-$165.95M	-$5.57	-21.20%	67.10%	N/A	N/A
AGL	AGILON HEALTH INC	$1.98B	$4.32B	-$234.99M	-$262.60M	-$0.64	80.74%	55.50%	N/A	N/A	2024-05-29
WAT	WATERS CORP	$19.02B	$2.96B	$1.00B	$642.23M	$10.87	-0.52%	4.09%	-7.88%	7.11%	2024-05-23
IGMS	IGM BIOSCIENCES INC	$591.98M	$2.13M	-$232.05M	-$246.42M	-$4.71	99.25%	N/A	N/A	N/A	2024-06-11
OTRK	ONTRAK INC	$11.25M	$12.74M	-$14.42M	-$36.87M	-$3.30	-12.20%	-3.44%	N/A	N/A	2024-05-14
EYPT	EYEPOINT PHARMACEUTICALS INC	$983.66M	$46.02M	-$69.00M	-$70.80M	-$1.82	11.14%	58.70%	N/A	N/A	2024-06-20
SPRB	SPRUCE BIOSCIENCES INC	$30.61M	$10.09M	-$47.14M	-$47.92M	-$1.24	N/A	N/A	N/A	N/A	2024-05-22
CSTL	CASTLE BIOSCIENCES INC	$671.68M	$250.73M	-$17.87M	-$30.80M	-$1.14	64.71%	55.20%	N/A	N/A
RVMD	REVOLUTION MEDICINES INC	$6.62B	$11.58M	-$430.28M	-$436.37M	-$3.86	-67.27%	-10.50%	N/A	N/A	2024-06-20
TOI	ONCOLOGY INSTITUTE INC	$79.51M	$324.24M	-$55.26M	-$67.88M	-$0.92	28.42%	N/A	N/A	N/A	2024-06-13
HCSG	HEALTHCARE SERVICES GROUP INC	$796.85M	$1.68B	$79.07M	$41.01M	$0.57	-0.18%	-3.24%	23.91%	-14.53%	2024-05-28
NNOX	NANO-X IMAGING LTD	$539.94M	$9.91M	-$50.96M	-$60.78M	-$1.08	15.47%	N/A	N/A	N/A	2024-05-20
ALT	ALTIMMUNE INC	$517.54M	$426.00k	-$87.94M	-$88.45M	-$1.66	N/A	-47.15%	N/A	N/A	2024-05-15
RCEL	AVITA MEDICAL INC	$224.93M	$51.57M	-$32.79M	-$35.38M	-$1.40	37.03%	N/A	N/A	N/A	2024-06-05
TECH	BIO-TECHNE CORP	$12.15B	$1.14B	$372.91M	$224.16M	$1.41	2.25%	10.93%	-15.57%	17.11%
TMDX	TRANSMEDICS GROUP INC	$4.22B	$296.92M	$14.01M	-$10.20M	-$0.32	149.23%	81.26%	N/A	N/A	2024-05-23
PLRX	PLIANT THERAPEUTICS INC	$842.14M	$1.58M	-$155.84M	-$161.34M	-$2.75	-83.69%	N/A	N/A	N/A	2024-06-13
CDIO	CARDIO DIAGNOSTICS HOLDINGS INC	$16.56M	$17.07k	-$1.53M	-$8.38M	-$0.66	1,696.32%	N/A	N/A	N/A
BGNE	BEIGENE LTD	$16.98B	$2.46B	-$812.17M	-$881.71M	-$0.65	73.65%	65.47%	N/A	N/A	2024-06-05
RYTM	RHYTHM PHARMACEUTICALS INC	$2.63B	$77.43M	-$168.46M	-$184.68M	-$3.20	227.56%	N/A	N/A	N/A	2024-05-07
IART	INTEGRA LIFESCIENCES HOLDINGS CORP	$2.26B	$1.54B	$258.15M	$67.74M	$0.85	-1.03%	0.92%	-61.01%	3.09%	2024-05-06
CALT	CALLIDITAS THERAPEUTICS AB	$595.80M	$110.93M	-$31.50M	-$42.85M	-$1.60	55.09%	N/A	N/A	N/A	2024-05-13
SERA	SERA PROGNOSTICS INC	$351.82M	$306.00k	-$34.76M	-$36.24M	-$1.16	14.18%	N/A	N/A	N/A	2024-05-08
SPRY	ARS PHARMACEUTICALS INC	$940.89M	$30.00k	-$54.29M	-$54.37M	-$0.57	-97.72%	N/A	N/A	N/A	2024-06-20
PRE	PRENETICS GLOBAL LTD	$63.83M	$21.74M	-$55.20M	-$62.72M	-$5.58	65.17%	18.68%	N/A	N/A
BRNS	BARINTHUS BIOTHERAPEUTICS PLC	$84.85M	$802.00k	-$69.64M	-$73.35M	-$1.91	-98.21%	N/A	N/A	N/A	2024-05-10
SBFM	SUNSHINE BIOPHARMA INC	$835.40k	$24.09M	-$3.82M	-$4.51M	-$19.00	454.42%	N/A	N/A	N/A	2024-05-09
ITOS	ITEOS THERAPEUTICS INC	$417.93M	$12.60M	-$108.13M	-$112.64M	-$3.15	-95.29%	N/A	N/A	N/A	2024-06-11
MREO	MEREO BIOPHARMA GROUP PLC	$457.24M	$10.00M	-$27.34M	-$29.47M	-$0.20	N/A	N/A	N/A	N/A	2024-05-23
INNV	INNOVAGE HOLDING CORP	$549.03M	$720.80M	-$12.92M	-$31.56M	-$0.24	4.63%	N/A	N/A	N/A	2024-05-07
IFRX	INFLARX NV	$81.26M	$68.58k	-$45.72M	-$46.38M	-$0.85	N/A	N/A	N/A	N/A	2024-05-08
BFLY	BUTTERFLY NETWORK INC	$198.70M	$68.08M	-$110.58M	-$121.92M	-$0.58	-7.11%	N/A	N/A	N/A
IMCR	IMMUNOCORE HOLDINGS PLC	$3.00B	$249.43M	-$50.00M	-$55.29M	-$1.13	43.05%	53.19%	N/A	N/A	2024-05-31
VCYT	VERACYTE INC	$1.53B	$361.05M	-$45.27M	-$74.40M	-$1.02	21.76%	31.45%	N/A	N/A	2024-05-07
SAGE	SAGE THERAPEUTICS INC	$838.94M	$91.06M	-$501.74M	-$503.14M	-$8.39	868.87%	0.07%	N/A	N/A	2024-06-10
ZLAB	ZAI LAB LTD	$1.61B	$266.72M	-$316.88M	-$334.62M	-$3.50	24.03%	360.35%	N/A	N/A	2024-05-08
EDAP	EDAP TMS SA	$264.92M	$65.68M	-$21.41M	-$23.02M	-$0.62	14.52%	8.31%	N/A	N/A	2024-05-16
IMTX	IMMATICS NV	$911.76M	$58.69M	-$97.57M	-$105.43M	-$1.30	-67.37%	69.15%	N/A	N/A	2024-06-05
APRE	APREA THERAPEUTICS INC	$29.05M	$583.23k	-$15.50M	-$14.29M	-$3.95	N/A	N/A	N/A	N/A	2024-05-13
CMRX	CHIMERIX INC	$85.42M	$41.00k	-$82.60M	-$82.59M	-$0.94	-99.88%	-65.81%	N/A	N/A	2024-06-20
QSI	QUANTUM-SI INC	$260.86M	$1.08M	-$90.40M	-$95.96M	-$0.68	N/A	N/A	N/A	N/A	2024-05-15
OCS	OCULIS HOLDING AG	$469.12M	$981.11k	-$96.77M	-$98.67M	-$3.30	7.19%	N/A	N/A	N/A
IQV	IQVIA HOLDINGS INC	$40.70B	$15.07B	$3.27B	$1.36B	$7.42	3.97%	7.43%	30.86%	43.25%
LXRX	LEXICON PHARMACEUTICALS INC	$428.45M	$2.31M	-$176.77M	-$193.58M	-$0.83	1,734.13%	-45.27%	N/A	N/A
VRDN	VIRIDIAN THERAPEUTICS INC	$966.62M	$314.00k	-$235.32M	-$237.73M	-$5.31	-82.28%	-48.16%	N/A	N/A	2024-06-17
RGEN	REPLIGEN CORP	$9.33B	$607.45M	$106.35M	$14.84M	$0.28	-21.90%	23.69%	-90.73%	-10.22%	2024-05-16
AXGN	AXOGEN INC	$253.05M	$163.73M	-$9.93M	-$21.28M	-$0.50	13.51%	12.72%	N/A	N/A	2024-06-05
KRRO	KORRO BIO INC	$467.20M	$0.00	-$73.91M	-$81.17M	-$53.08	N/A	N/A	N/A	N/A	2024-06-11
BEAM	BEAM THERAPEUTICS INC	$1.89B	$377.71M	-$111.15M	-$132.53M	-$1.72	520.01%	N/A	N/A	N/A	2024-06-05
PSNL	PERSONALIS INC	$77.78M	$73.48M	-$94.95M	-$108.30M	-$2.25	12.97%	14.23%	N/A	N/A	2024-05-08
CASI	CASI PHARMACEUTICALS INC	$37.39M	$33.88M	-$22.29M	-$26.96M	-$2.02	-21.41%	N/A	N/A	N/A
PRPO	PRECIPIO INC	$8.30M	$15.20M	-$4.32M	-$5.85M	-$4.51	61.46%	39.62%	N/A	N/A	2024-06-14
MTEM	MOLECULAR TEMPLATES INC	$8.98M	$57.31M	$1.16M	-$8.12M	$1.80	190.10%	33.96%	-92.71%	N/A	2024-05-13
GRFS	GRIFOLS SA	$4.52B	$7.09B	$1.23B	$63.78M	$0.10	13.54%	7.27%	-69.70%	-36.90%	2024-06-14
ACB	AURORA CANNABIS INC	$320.76M	$199.23M	-$66.17M	-$106.90M	-$3.96	30.77%	17.87%	N/A	N/A	2024-06-12
CTKB	CYTEK BIOSCIENCES INC	$813.73M	$193.02M	-$4.41M	-$12.15M	-$0.09	17.67%	N/A	N/A	N/A	2024-06-05
OPRX	OPTIMIZERX CORP	$193.11M	$71.52M	-$21.31M	-$17.57M	-$1.03	14.53%	27.52%	N/A	N/A	2024-06-05
BLUE	BLUEBIRD BIO INC	$98.40M	$21.73M	-$95.08M	-$91.17M	-$0.60	322.60%	-11.27%	N/A	N/A	2024-06-14
ALHC	ALIGNMENT HEALTHCARE INC	$1.27B	$2.01B	-$110.85M	-$157.25M	-$0.84	31.76%	N/A	N/A	N/A	2024-06-07
ARVN	ARVINAS INC	$2.23B	$78.50M	-$359.70M	-$367.30M	-$6.62	-40.26%	40.53%	N/A	N/A	2024-05-29
ELMD	ELECTROMED INC	$159.20M	$51.69M	$6.01M	$3.94M	$0.47	18.03%	11.25%	88.00%	15.36%	2024-05-07
EMBC	EMBECTA CORP	$584.43M	$1.12B	$207.60M	$55.30M	$0.96	0.58%	N/A	-66.08%	N/A	2024-05-09
LQDA	LIQUIDIA CORP	$972.40M	$17.49M	-$69.65M	-$78.50M	-$1.21	9.75%	45.23%	N/A	N/A	2024-06-20
MESO	MESOBLAST LTD	$761.10M	$7.25M	N/A	-$73.06M	-$0.91	-5.28%	-14.93%	N/A	N/A	2024-05-30
SILK	SILK ROAD MEDICAL INC	$794.46M	$177.13M	-$45.08M	-$55.74M	-$1.44	27.77%	38.66%	N/A	N/A	2024-06-18
TXG	10X GENOMICS INC	$3.29B	$625.45M	-$210.40M	-$264.30M	-$2.23	16.64%	N/A	N/A	N/A	2024-06-11
CRBU	CARIBOU BIOSCIENCES INC	$340.49M	$34.48M	-$96.30M	-$102.07M	-$1.38	148.91%	N/A	N/A	N/A	2024-05-07
AUPH	AURINIA PHARMACEUTICALS INC	$729.40M	$191.41M	-$41.87M	-$62.56M	-$0.42	30.37%	233.64%	N/A	N/A	2024-06-14

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	681	+1.07%	+6.00%	-2.53%	-18.30%	6.05x	6.01x	+14.40%	+2.29%	-33.91%	+80.46%	Strong Buy
Diagnostics & Research	66	+0.85%	+0.70%	-4.26%	-0.73%	38.44x	4.21x	-23.57%	+6.35%	+11.16%	+10.51%	Buy
Drug Manufacturers - General	17	+0.84%	+2.91%	-0.54%	+12.68%	148.07x	6.24x	+33.79%	+8.12%	+14.24%	+13.81%	Buy
Drug Manufacturers - Specialty & Generic	90	-0.21%	+4.09%	+0.45%	-3.63%	33.76x	2.15x	+11.91%	+3.10%	+5.65%	+32.15%	Strong Buy
Healthcare Plans	12	+0.01%	-1.01%	-0.15%	-0.05%	19.70x	2.90x	+19.64%	+6.04%	+14.10%	+17.24%	Buy
Health Information Services	61	+0.46%	+1.33%	-3.77%	-22.81%	75.59x	3.24x	+6.63%	+2.09%	+5.13%	+34.77%	Buy
Medical Care Facilities	51	+0.10%	+2.08%	-4.18%	+7.39%	-7.32x	4.34x	-93.77%	+6.64%	+13.89%	+17.87%	Buy
Medical Devices	154	+0.93%	+3.67%	-0.50%	-12.74%	27.79x	3.71x	+10.38%	+5.26%	+7.71%	+19.09%	Buy
Medical Distribution	9	-1.40%	-4.69%	-6.08%	+30.95%	26.17x	109.10x	-8.59%	+3.48%	+18.93%	+10.93%	Buy
Medical Instruments & Supplies	56	+0.43%	+1.57%	-1.02%	-12.24%	56.77x	3.54x	+11.45%	+7.81%	+10.28%	+19.60%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in May 2024?

According to Zen Score, the 3 best healthcare stocks to buy right now are:

1. Cross Country Healthcare (NASDAQ:CCRN)

Cross Country Healthcare (NASDAQ:CCRN) is the top healthcare stock with a Zen Score of 70, which is 45 points higher than the healthcare sector average of 25. It passed 22 out of 33 due diligence checks and has strong fundamentals. Cross Country Healthcare has seen its stock lose -22.25% over the past year, underperforming other healthcare stocks by -14 percentage points.

Cross Country Healthcare has an average 1 year price target of $20.25, an upside of 21.48% from Cross Country Healthcare's current stock price of $16.67.

Cross Country Healthcare stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Cross Country Healthcare, 25% have issued a Strong Buy rating, 25% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Semler Scientific (NASDAQ:SMLR)

Semler Scientific (NASDAQ:SMLR) is the second best healthcare stock with a Zen Score of 68, which is 43 points higher than the healthcare sector average of 25. It passed 21 out of 33 due diligence checks and has strong fundamentals. Semler Scientific has seen its stock return 1.39% over the past year, overperforming other healthcare stocks by 10 percentage points.

3. Progyny (NASDAQ:PGNY)

Progyny (NASDAQ:PGNY) is the third best healthcare stock with a Zen Score of 67, which is 42 points higher than the healthcare sector average of 25. It passed 22 out of 33 due diligence checks and has strong fundamentals. Progyny has seen its stock lose -6.98% over the past year, overperforming other healthcare stocks by 1 percentage points.

Progyny has an average 1 year price target of $47.00, an upside of 48.17% from Progyny's current stock price of $31.72.

Progyny stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Progyny, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 72 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Mei Pharma (NASDAQ:MEIP)

Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 57.19%, which is 54 percentage points higher than the healthcare sector average of 2.79%.

Mei Pharma's dividend payout ratio of 58.9% indicates that its high dividend yield is sustainable for the long-term.

2. Siga Technologies (NASDAQ:SIGA)

Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 10.34%, which is 8 percentage points higher than the healthcare sector average of 2.79%.

Siga Technologies's dividend payout ratio of 47.4% indicates that its high dividend yield is sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 8.69%, which is 6 percentage points higher than the healthcare sector average of 2.79%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 148.8% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.65% in the last day, and up 2.85% over the last week. Twist Bioscience was the among the top gainers in the healthcare sector, gaining 28.74% yesterday.

Twist Bioscience shares are trading higher after the company reported better-than-expected Q2 financial results.

What are the most undervalued healthcare stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare stocks right now are:

1. Inmode (NASDAQ:INMD)

Inmode (NASDAQ:INMD) is the most undervalued healthcare stock based on WallStreetZen's Valuation Score. Inmode has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Inmode's stock has dropped -47.67% in the past year. It has underperformed other stocks in the healthcare sector by -39 percentage points.

2. Pacira Biosciences (NASDAQ:PCRX)

Pacira Biosciences (NASDAQ:PCRX) is the second most undervalued healthcare stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -36.9% in the past year. It has underperformed other stocks in the healthcare sector by -28 percentage points.

3. Semler Scientific (NASDAQ:SMLR)

Semler Scientific (NASDAQ:SMLR) is the third most undervalued healthcare stock based on WallStreetZen's Valuation Score. Semler Scientific has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Semler Scientific's stock has gained 1.39% in the past year. It has overperformed other stocks in the healthcare sector by 10 percentage points.

Are healthcare stocks a good buy now?

48.04% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 35.99% over the next year.

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 68.89x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.